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Background
Pseudomonas aeruginosa is an important opportunistic
pathogen causing serious pulmonary, urogenital and sys-
temic infections. P. aeruginosa injects four effector pro-
teins into host cells via the type III secretion system. ExoY
is one of these proteins.
ExoY was originally classified as adenylyl cyclase with
homology to the typical calmodulin-stimulated adenylyl
cyclase exotoxins CyaA from Bordetella pertussis and
edema factor from Bacillus anthracis, but the pathophy-
siologial function of ExoY has remained elusive [1,2].
Recently, our group showed that CyaA and edema factor
possess a rather broad base specifity (ATP >> CTP >
UTP) [3,4], raising the question of wether ExoY may also
bind and metabolize nucleoside 5’- triphosphates other
than ATP.
Methods
We determined cyclic nucleotide concentrations in cells
transfected with ExoY plasmid or infected with P. aerugi-
nosa with a highly sensitive HPLC-MS/MS method. More-
over, we determined the catalytic activity of purified ExoY.
Results
In mammalian cells transfected with ExoY plasmid and
infected with ExoY-encoding P. aeruginosa, massive pro-
duction of cGMP and cUMP was observed, with little
production of cAMP. Purified ExoY was a highly effective
nucleotidyl cyclase with the substrate preference GTP >>
UTP ~ ATP > CTP. Fluorescence resonance energy
transfer studies with methylanthraniloyl-substituted
nucleotides corroborated the preference of ExoY for
GTP. In contrast to ExoY, CyaA induced accumulation
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Table 1 Comparison of ExoY with CyaA and EF
Parameter ExoY CyaA EF
Bacterial source Pseudomonas aeruginosa Bordetella pertussis Bacillus anthracis
Secretion type III I II
Function as toxin Unknown, “antitoxin?” yes yes
Activation mechanism Cytosolic cofactor (mammalian cells and D.
discoideum)
calmodulin calmodulin
Substrate-specificity purified
enzyme
GTP >> UTP ≥ ATP > CTP ATP >> CTP > UTP >
GTP
ATP >> CTP > UTP >
GTP
Substrate-specificity intact cells UTP ~ GTP > ATP > CTP
(except for B103 cells)
ATP >> CTP > UTP >>
GTP (ineffective)
ATP >> CTP >>
UTP and GTP(ineffective)
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in mammalian cells, and edema factor induced only
cAMP- and cCMP accumulation.
Conclusion
ExoY is a nucleotidyl cyclase with preference for GTP,
and the substrate-specificity of ExoY is clearly different
from that of CyaA and edema factor. Our data open the
door for future studies aiming at the elucidation of the
as yet unknown pathophysiological function of ExoY
and which role cCMP, cGMP and cUMP play in this
process.
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